throbber
No. 5
`
`'
`
`f
`
`1085
`
`Ch
`.Ph
`. B '.
`[23(iiniiossji330(19liii)
`
`,‘
`7
`,
`UPC 547. 92.93
`
`Solubilization of Steroids by Multiple co-Solvent Systems
`
`YIE W. 'CHIEN” and HOWARD J. LAMBERT
`
`Biopkarmacentios Section Product Development Department Searle Laboratories”
`
`(Received September 27, 1974)
`
`The aqueous solubility of steroids was exponentially increased following the addition
`of a co-solvent. A theoretical equation was derived to describe the relationship between
`the amount of drug solubilized and the volume fraction of co-solvent incorporated. Both
`single and multiple co-solvent systems fellowed the derived relationship.
`
`Introduction
`
`In the practice of pharmaceutical formulation, the challenge of improving the solubility
`of many poorly soluble drugs, leg, steroids, in solution dosage forms is common. To solve
`such problems, scientists often incorporate one or more co—solvents with distilled water to
`overcome the poor aqueous solubility.
`.'
`Ethanol, propylene glycol, and several members of the polyethylene glycol polymer
`series, e’.g., polyethylene glycol 400, represent the limited number of co—solVents that are both
`useful and generally acceptable in the formulation of aqueous liquids”.
`In addition, Spiegal
`and Noseworthy3) in their review of nonaqueous solvents used in parenteral products, also
`suggested a number of co-solvents, such as 2,2-dimethyl—l,3-dioxolane—4—methanol (Solketal),
`dimethylacetamide, glycerol formal, glycoiurol,
`'N—(fl—hydroxyethyl)-lactamide, and ethyl
`lactate.
`
`There have been several reports dealing with the systematic investigation of drug solubility
`and solvent compositionfia‘l‘” Observations to date indicate that the solubility of many
`drugs and druglike substances in binary! aqueous systems is enhanced exponentially by the
`addition of a c0-solvent.4’
`
`Past experiences in our laboratories with solution dosage formulation indicated that the
`semilogarithmic relationship of drug solubility to c0~solvent composition was followed not
`only in binary aqueous systems containing a single co-solvent, but also in the systems
`containing 2 or more different co-solvents.
`In this paper, the authors will report their obser-
`vations on the dependency of steroid solubility on the concentration of single, binary, and/or
`ternary co~solvents, and will present a theoretical analysis on the semilogarithmic relationship
`of drug solubility to co—solvent concentration.
`
`Experimental
`
`_ MaterialeC—9376, $04640, SC—11800, and SC-25152 (Fig. 1) (Searle Laboratories, Skokie, Illinois),
`propylene glycol, polyethylene glycol 400, 2,2-dimethyl-1,3-dioxolane—4—methanol, and N,N-dimethylacet—
`amide (Matheson Coleman Bell (30., Norwood, Ohio) and 95 % ethanol for medical use were utilized as obtained.
`
`.
`1) Location: Skokie, Illinois 60076, U.S.A.
`2) L. Lachman, ILA. Lieberman, and IL. Kanig, "The Theory and Practice of Industrial Pharmacy,”
`Lea & Febiger, Philadelphia, 1970, Chapter 15.
`'
`i
`3) A.J. Spiegel and M.M. Noseworthy, ]. Phomn. 805., 52,! 917 (1963).
`4) S.H. Yalkowsky, G.L. Flynn, and G.L. Amidon, J. Pharm. 5613, 61, 983 (1972).
`5) A.N. Parnta and S.A. Irani, J. Pharm. SOL, 54, 1334 (1965),
`V
`' 6) W.G. Gorman and G.D.'Hall, J. Pharm. Sell, 53, 1017 (196.4).
`7) KS. Lin, J. Anschel, and CJ. Swartz, Bull. Parenteral Drug Anson, 25, 40 (1971).
`
`NIT—Electronic Library Service
`
`InnoPharma Exhibit 1098.0001
`
`

`

`
`
`1086 Vol. 23 (197,5)
`
`gRrenteral quality distilled water was prepared and used for the preparation of 0»~SQ%~co-solvent—water
`combinations. Absolute methanol (spectroquality, ].T. Baker Chemical, Cleveland, Ohio) was"employed
`for the dilution of filtered drug solutions to an appropriate concentration for spectrophotometric measurement.
`
`0
`
`Hg-Co‘é
`
`l
`1
`i
`'
`"
`_
`SC 9376(pamemng)
`
`.
`
`‘
`
`8.071108%
`f
`"j
`$945640":
`-
`I;
`‘iethynodiol'.diacetate)
`U
`(‘nor‘ethindronfl
`.
`V
`2:515? ,
`,
`Fig. 1. Molecular Structures of the Steroids investigated
`
`i
`
`
`Determination of Drug Solubility
`The methodology reported earlier” was adopted here with minor
`modificationsto avoid the possible hydrolysis of SC-9376 and SC-25152 after‘48-hour equilibration at 37°.
`Excess drug solid was equilibrated with 10 ml of a co—solvent—Water combination at 37° for 2 hours with
`constant ‘sha'king.
`v Aftercooling to room temperature, the over-saturated drug solution Was quickly [filtered
`through a filter holder (millipore) containing a glass fiber membrane (Reeve’Angel). The filtered ‘dru'g
`solution was diluted 10 to 4000 times With methanol to an appropriate drug concentration and then read
`spectrophotometrically. Themagnitude'of the absorbance at the A max was used to calculate the amount
`of a drug solubilized in a given solvent system. The filtered solution" of ethynodiol diacetate (SC-11,800)
`was subjected to acidic hydrolysis” before dilution.
`v
`‘
`'
`
`Results and Discussions “
`
`I
`
`In nonideal‘solutions,‘9> the solubility of a drug“(Cw) in pure Water system is defined by I,
`
`gASw
`2.303RT
`
`10g cw = —
`
`(Tm—r) + log y“,
`
`"
`
`(1)
`
`Also, the solubilities of this drug (CA, CB, or CX) in pure systems of co-solvent A, B, or
`may be defined in the same way:
`I
`
`‘
`
`1
`
`0g
`
`ASA
`c =—-——T —T
`1
`'
`2.303RT,( m H 0g“
`. A53
`= —————T —T
`1
`25303RT( m
`)+ Ogys
`Asx
`w
`z
`= ——— T —:r
`1
`2.303RT( m
`)\+ 037’):
`
`10% CB
`
`,
`
`10% CX
`
`i
`
`7
`
`.
`
`~
`
`V
`
`‘
`
`I
`
`_
`
`'
`
`'
`
`_
`
`*
`
`2
`()
`3
`()
`
`4
`( )
`
`where ASW, ASA, ASE, and ASx are the entropies of thedrug species in the pure solvent systems
`and W, 32A, 3213, and 32,; are the corresponding activity coefficients; Tm is the drug melting point;
`. and T is the temperature of the system investigated.
`,
`it

`In a nonideal multiple solvent system containing fA fraction of co—solvent A, fB fraction
`5of co-solvent B, fX fraction of co-solvent X, and [1—(fA —|—fB +fx)] fraction of water, the apparent
`solubility (CA, B, X) of the same drug species may be expressed as
`log CA,’B,X = fw 10g Cw
`fA 10g CA
`CB + fx
`CX
`f.
`= 10% Cw + fAGOg CA—Iog Cw.) .+. fB,(10g Cfi—logcw),
`
`,
`
`_
`
`#
`
`
`
`.
`8) Y.W. Chien, H.J. Lambert, and D.E. ‘Granti’ji 131mm; sax} 6,3, 365 (197.4).
`9) A.N. Martin, “Physical 'Pharmacy,"~Lea, & Febiger; Philadelphia',*19§0,x Chapter. 14.
`
`,
`
`NII—Electronic Library Service
`
`InnoPharma Exhibit 1098.0002
`
`

`

`No. ,5
`
`~
`
`-
`
`1087'
`
`since
`
`
`
`
`
`
`
`r
`
`‘
`(ASw—ASA) + log—31::—
`165; CA —- log CW =
`(Asa—ASE) + log if
`log CB —— 10g CW =
`(Ase—ASX) + log g:—
`log Cx — 10g 0.. =
`Substituting Eqs. (6), (7), and (8) into (Si-b) gives
`(9)
`10g CA,B,x =10g CW) + SAfAV'i' ssz + exfx
`where the slopes (EA, 3],, and ex) of the semilogarithmic relationship between the drug solubility
`(CA, B, X) and the composition of co-solvent (fA, f3, and fx) are defined by:
`
`'71».
`(meT)
`.
`:
`1 ——
`A w—AS
`>,:A)+ 0g VW
`2.303RT( S
`
`(TnamT) A
`Sw—A
`2.3031zr( ,
`
`(Tm'"T) A
`2.303RT( S
`
`(6) ‘
`(7)":
`at
`
`(10)
`
`(1D
`
`,
`
`(12)
`
`=
`
`8A
`
`=
`
`=
`
`8”
`
`ax
`
`7’3
`’
`l —
`3‘9ng
`A
`‘
`7X
`w~ s
`1
`.—
`x)+ 0g yw
`
`‘
`v
`
`-
`
`:
`
`.
`
`_
`
`Eqs. (10) to (12) point out that the magnitudes of the slopes (3A, 83, and ex) are determined by
`the difference in entropies, MSW—ASA), (ASw—ASB), and (ASWQ—ASX), respectively,the ratio
`of the activity coefficients (yA/yw, 723/32,, and yX/yw and the difference between the melting
`point temperature (Tm) and the temperature of the system studied (T).
`Eq. (9) indicates that the solubility of a drug species in a given multiple co—solvent system
`(CA, B, x,) is exponentially related to the volume fractions of co-solvents (A, B, and X) added.
`In the case of a ternary system containing a fixed (fA) of co-solvent A and a varying fraction
`(fx) of co-solvent X, Eq. (9) may be simplified. Since fB=O, the apparent drug solubility
`(CA, x) in such a ternary system is:
`
`log CA,X = log CW + £AfA + exfx
`
`(13)
`
`When using a binary system, (only one co—solvent), Eq. (13) may be further simplified to
`log Cx = log Cw + exfx
`,
`‘
`i (14)
`An equation similar to Eq. (14) was reported previously by Yalkowsky, et all“ to describe
`the solubility of alkyl p—aminobenzoates in propylene glycol~water systems.
`The experimental evidence for the dependence of drug solubility upon co—solvent composi-
`tion in a binary system (Eq. 14) is demonstrated in Fig. 2, where the solubility of poorly soluble
`steroids, e.g., progestins (SC—11800 and 804640) as well as anti-mineralcorticoid drugs (SC-9376
`and 8025152), is exponentially enhanced as the volume fraction of polyethylene glycol 400
`co—solvent increases. The molecular structures of the four synthetic steroids investigated
`were shown earlier in Fig. 1.
`I
`i
`.
`,
`Eq. (14) was also followed in binary systemslcontaining either ethanol, propylene glycol,
`solketal (2,2-dimethyl—1,3-dioxolane—4—methanol), or‘ dimethylacetamide. For example, the
`solubilization of canrenone by ethanol, propylene glycol, and PEG 400 is illustrated in Fig. 3,
`A common ordinate intercept, which was equivalent to the actual aqueous solubility (Cw)
`of canrenone (8.1 X 10%) measured independently, was obtained. The relative efficiency
`on the solubilization of canrenone by these five co-solvents is tabulated in Table I in order
`of solubilizing efficiency. Ethanol is the most effective solubiliz‘er and polyethylene glycol
`400 is least effective.
`,
`'
`v
`I.
`'_
`,
`j_
`;«
`A
`;
`The validity of Eq,
`(13) in a ternary system containing a fixed (fA) volume fraction of
`co—solvent A and a varying fraction (fx) of co—solvent X is demonstratedby the datavin‘Fig..4=-.
`In this experiment, the incorporation 'ofua fixed concentration (19 or 28.5% v/v), of ethanol
`
`NIT—Electronic Library Service
`
`InnoPharma Exhibit 1098.0003
`
`

`

`1088
`
`Vol. 23 (1975)
`l N
`
`ca X ._. o
`
`4X10—2
`
`N l'
`
`t—I o:
`
`EEI
`D0
`
`’8
`
`5 10‘8
`g;
`g
`w
`o
`>,
`3% 10“
`~g
`__5
`U)
`
`10-5
`
`V
`
`1.0
`
`0.8
`0.6
`0.4
`» 0.2
`0
`‘Volume fraction of polyethylene
`glyCOI 400
`Solubihmtion of some Syflthe_
`Fig 2
`tic Steroids by the- Addition of Poly_
`eth lene Glycol
`y
`keys: . EEC-11800, 0 804640, I 809376, and
`D 5025152
`
`(moles/liter)
`
` 10"2-
`
`‘
`
`canrenone
`
`' 10‘9
`
`“a
`<>a
`a
`L5
`3
`c8
`
`.
`
`10f4
`‘ 5X10_5___._I_._L_____1_~J_____1
`0
`0.2
`0.4
`0.6
`0.8
`1.0
`Volume fraction of co-solvent
`
`’
`
`'
`
`.
`
`-
`
`Fig. 3. Semilogarithmic Relationship
`between the Concentration of Caan-
`none (moles/liter) solubilized and the
`Volume Fraction of a Single 00—
`Solvent
`.
`'
`F
`A common intercept at 8.1 X 10‘“M was observed:
`keys: 0 ethanol, 0 propylene glycol, and .
`polyethylene glycol 400
`
`TABLE I. The Solubilization of Canrenone by the Binary
`Systems Containing a Single co-Solvent and Water
`
`
`
` Solubilizers ex“)
`
`Ethanol
`Solketal
`-
`I Propylene glycol
`v
`' Dimethylacetarnide
`Polyethylene g1ycol‘400'
`
`.
`
`4.75
`3.97
`3.42
`3.21
`2.93
`
`a) axis the slope of the log OK as. fx profiles as defined in Eq. (14).
`
`substantially enhanced the magnitude of the intercept (from log CW to leg CW+£AfA) (compare
`Eqs; 14 with 13); but, the linear relationship of log CA, x to fx was still followed and the magni—
`tude of the slope (ex) stayed about the same (ex=8.34 to 3.43).
`‘ When a fixed concentration of a third co~solvent, e.g., solketal (20% v/v) or dimethyl—
`acetamide (20% v/V) f was incorporated into mixtures of ethanol—propylene glycol—water,
`the solubility of canrenone was enhanced. The linearity of log CA, B, X to the volume fraction
`0f propylene glycol (as expected from Eq.
`(9)) was still observed. Following the addition
`of 20% V/V of either dimethylacetamide Or solketal (Fig 5) the intercept (at zero concentration
`‘of propylene glycol) was significantly increased from log Cw +8AfA (Eq. 13) to log Cw—l—eAfA +83fB
`(Eq. 9). The effectof addition of a third solubilizer on the magnitude of both the intercept
`(log CW+aAfA+stB) and the slope (ex) of the log CA, B, X vs.fW profiles are found in Table II.
`Along with the increase in the intercept, the slopes were slightly minimized due to the addition
`Of) a third co-solve‘nt. This may be due to the change in the entropy and activity coeflicient
`‘of the resultant solution. The predictive value of Eq.
`(9')
`is demonstrated in Table III.
`
`NIT—Electronic Library Service
`
`InnoPharma Exhibit 1098.0004
`
`

`

`N0. 5‘
`
`1089
`
`6X10’a
`
`3X10—l
`‘
`
`
`
`Solubilityofcanrenone(moles/liter)
`
`J.
`
`H
`
`..o
`
`
`
`n
`
`l—l
`
`,9
`
`
`
`A,
`
`H,9.
`
`
`
`
`—5
`10—47
`1'.o
`.0.8
`0.6
`0.4
`0,2
`5X10 0
`Volume fraction of propylene glycol
`I
`Fig. 5. Semilogarithmic Relationship
`between the Concentration of Game-
`
`none (moles/liter) solubilized and the
`Volume Fraction of Propylene Glycol
`in a Three co-Solvent Aqueous System
`
`keys’ 0 Propylene 313m] alone, l: Plus 95%
`ethanol and 20% dimethylacetamide, I plus 19%
`ethanol and 20% dimethylacetamide, and . plus
`19% ethanol and 20% solketal
`
`i.
`
`‘
`
`N
`
`t. on
`
`5—. O
`
`J»
`
`0\
`
`
`
`
`
`Solubilityofcanrenone(moles/liter)
`
`"”
`4{/
`1°C
`5x10‘5_.
`
` 0
`
`Volume fraction of propylene glycol
`
`Fig. 4. Semilogarithmic Relationship
`between the Concentration (moles/
`liter) of Canrenone solubilized and the
`Volume Fraction of Propylene Glycol
`in a Two co-Solvent Aqueous System
`
`keys: 0 propylene glycol alone, 0 plus 19% v/v
`of ethanol, and . plus 28.5% v/v of ethanol
`
`TABLE II. Effect of the Addition of Third co-Solvent on the Intercept
`and Slope Values of log CA,3,X vs. fx Profiles (Eq. 9)
`co—Solvent combinations
`
`
`:fi: 1
`
`# 2
`
`# 3
`
`Intercept
`(MX103)
`
`
`Slope
`
`Propylene glycol
`Propylene glycol
`Propylene glycol
`Propylene glycol
`Propylene glycol
`
`—
`19.0% ethanol
`9.5% ethanol
`19.0% ethanol
`19.0% ethanol
`
`——
`—
`20% DMA
`20% DMA
`20% solketal
`
`3.42
`0.081
`3.43
`0.80
`3.00
`2.06
`2.39
`7.00
`
`13.80 2.08
`
`The product of the slope (6) (obtained from the solubilization of canrenone with individual
`co—solvents) and the volume fraction (f’5) used was employed to estimate the expected can—
`renone solubility in multi—co—solvent systems. The agreement of the observed solubility
`with that calculated is good. The small deviation of the observed solubility from the estimated
`value (low ratio, ca. 0.76) may be due to the slight decline in slope (Table II) observed after
`the incorporation of a third co-solvent.
`The use of multiple co-solvent combinations to enhance steroid solubility is an improve—
`ment over solubilization with a high volume fraction of a single co—solvent. For example,
`55% ethanol, or 77% propylene glycol, or 87% polyethylene glycol 400 was required in order
`to effectively solubilize 3.25X 10—2M of canrenone in aqueous solution. The use of high co-
`solvent concentrations may unfavorably affect the desired Viscosity, and the esthetic accepta-
`bility of the resultant formulations. On the other hand, this drug concentration (3.25 X lO—ZM)
`was achieved with a multiple co-solvent system containing either 9.5% ethanol—20% dimethyl-
`acetamide—étOo/0 propylene glycol or 19% ethanol—20% solketal—18% propylene glycol.
`In
`
`NIT—Electronic Library Service
`
`InnoPharma Exhibit 1098.0005
`
`

`

`1090
`
`Vol. 23 (1975-)
`
`TABLE III. Agreement betweenlCalculated and Observed Canrenone Solubility
`‘
`in Multiple co-Solvent Systems
`
`log}.
`“
`Multiple
`co—Solvent sYstems“)
`CA, 3, x”)
`‘
`Calculatedd)
`Observed
`
`
`Canrenone ‘isolubility ,‘(M X 102)
`
`Ratio”)
`
`‘
`
`1.368
`40%
`Propylene glycol
`0 . 451
`9. 5%
`Ethanol
`0.642
`20%
`DMAe)
`2.461
`SUI“ ,
`p
`- 1.368:
`Propylene glycol
`40%
`0 . 903
`Ethanol
`19%
`0.642
`DMAe>
`20%
`1 2.91.3
`SUM
`'
`1.368
`Propylene glycol
`40%
`' 0.903
`Ethanol
`19%
`O . 794
`Solketal
`20%
`
`V 3.065 11.61 9.61 1SUM 0.83
`
`
`2.89
`
`'
`
`3.25
`
`1.12
`
`8.18
`
`6.25
`
`0.76
`
`
`
`
`
`
`
`a) 9.8. of distilled water is added to make 100%
`[1)
`calculated from Table I by multiplying the slope (s) with volume fraction (f) for each cosolvent used
`c)
`ratio of observed solubility over calculated value
`'
`d)
`antilogaritbmic of log OMB”;
`e ) dimethylacetamide
`
`practice, any number of combinations may be blended depending on specific fermulation
`requirements and the physico—chemical properties of the drug. Finally, the use of a multiple
`co—solvent system may prevent the occurence of undesirable toxicity which may result from
`the use of a high volume fraction of a single co~solvent.
`
`Appreciation is extended to Ms. Dianne M. Jefferson for her
`Acknowledgements and Addresses
`technical assistance and to Ms. Susan M. Justi for manuscript preparation.
`
`NII—Electronic Library Service
`
`InnoPharma Exhibit 10980006
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket